Carisma Therapeutics, Inc.

DB:W2J Stock Report

Market Cap: €37.7m

Carisma Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Steve Kelly

Chief executive officer

US$3.5m

Total compensation

CEO salary percentage13.2%
CEO tenure1.5yrs
CEO ownershipn/a
Management average tenure1.4yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Steve Kelly's remuneration changed compared to Carisma Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$73m

Mar 31 2024n/an/a

-US$81m

Dec 31 2023US$4mUS$461k

-US$87m

Sep 30 2023n/an/a

-US$83m

Jun 30 2023n/an/a

-US$80m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$666kUS$440k

-US$61m

Sep 30 2022n/an/a

-US$57m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$1mUS$416k

-US$41m

Compensation vs Market: Steve's total compensation ($USD3.50M) is above average for companies of similar size in the German market ($USD509.52K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.

CEO

Steve Kelly (59 yo)

1.5yrs

Tenure

US$3,504,425

Compensation

Mr. Steven Kelly, also known as Steve, is President, Chief Executive Officer and Director of Carisma Therapeutics, Inc. He served as President, Chief Executive Officer and Director of CARISMA Therapeutics...

Leadership Team

NamePositionTenureCompensationOwnership
Steven Kelly
President1.5yrsUS$3.50mno data
Michael Klichinsky
Co-Founder & Chief Scientific Officer1.5yrsUS$1.60m1.17%
$ 439.3k
Richard Morris
CFO, Chief Compliance Officer1.5yrsUS$1.66m0%
$ 0
Saar Gill
Co-Founder & Chairman of Scientific Advisory Boardno datano datano data
Eric Siegel
General Counsel & Corporate Secretary1.3yrsno datano data
Terry Shields
Senior Vice President of Human Resources1.3yrsno datano data
Tom Wilton
Chief Business Officer4.7yrsno datano data
Eugene Kennedy
Chief Medical Officerless than a yearno datano data
Kenneth Locke
Senior Vice President of Technical Operationsless than a yearno datano data

1.4yrs

Average Tenure

52.5yo

Average Age

Experienced Management: W2J's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Steven Kelly
President1.5yrsUS$3.50mno data
Saar Gill
Co-Founder & Chairman of Scientific Advisory Boardno datano datano data
Sanford Zweifach
Independent Chairman of the Board1.5yrsUS$271.55k0.00099%
$ 373.1
Hyam Levitsky
Member of Scientific Advisory Boardno datano datano data
Nina Bhardwaj
Member of Scientific Advisory Board4.2yrsno datano data
Briggs W. Morrison
Independent Director1.5yrsUS$220.20k0.029%
$ 11.0k
Marella Thorell
Directorless than a yearno datano data
Michael Torok
Independent Director1.5yrsUS$207.95k0.24%
$ 91.8k
John Hohneker
Independent Directorless than a yearno data0%
$ 0
Lisa Coussens
Member of Scientific Advisory Boardno datano datano data
Prasad Adusumilli
Member of Scientific Advisory Board4.2yrsno datano data
Lin Guey
Member of Scientific Advisory Board1.6yrsno datano data

1.5yrs

Average Tenure

64yo

Average Age

Experienced Board: W2J's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.